Related Experiment Video
Updated: May 29, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Induction of apoptosis by evodiamine involves both activation of mitotic arrest and mitotic slippage
Li-Hong Zhu1, Wei Bi, Xiao-Dong Liu
1Department of Pathophysiology, Medical College of Jinan University, and Department of Neurology, First Affiliated Hospital of Jinan University, Guangzhou 510632, PR China.
Abstract:
Evodiamine (Evo) is an indole quinazoline alkaloid isolated from the fruit of Evodia rutaecarpa Bentham. Previous studies have shown that Evo exhibits anti-proliferative anti-tumor activities in several cancer types, but its target(s) and underlying mechanism(s) of action remain unclear. In the present study, we sought to establish a cell synchronization model in order to examine the anti-proliferative and apoptotic mechanisms of Evo in the human gastric cancer cell line SGC-7901. In addition, we transfected these cells with full-length or non-degradable (ND) cyclinB1 to evaluate the relationship between the induction of apoptosis and activation of mitotic arrest and mitotic slippage by Evo. Our results demonstrated that Evo markedly inhibited cell growth and was cytotoxic to SGC-7901 cells. Furthermore, transient Evo treatment (<16 h) caused reversible mitotic arrest, but sustained mitotic arrest was required to initiate apoptosis. The time required to reverse the apoptotic effects of Evo was between 16 and 20 h. We also demonstrated that promotion of mitotic slippage by a CDK1 inhibitor enhanced apoptosis. Furthermore, we evaluated the effect of delaying mitotic slippage by overexpressing ND cyclinB1, which delayed apoptosis. In conclusion, these results indicate that Evo-induced apoptosis is associated with mitotic arrest and subsequent mitotic slippage, which may underlie the actions of Evo in the treatment and prevention of cancer.
Insights
Evodiamine (Evo) inhibits gastric cancer cell growth by causing mitotic arrest and slippage. Sustained arrest is crucial for Evo to induce apoptosis, offering potential cancer treatment strategies.
Area of Science:
- Pharmacology
- Molecular Biology
- Cancer Research
Background:
- Evodiamine (Evo), an alkaloid from Evodia rutaecarpa, shows anti-proliferative and anti-tumor effects.
- The precise mechanisms and molecular targets of Evo's anti-cancer activity remain largely unelucidated.
- Understanding Evo's action is critical for its potential therapeutic applications in oncology.
Purpose of the Study:
- To investigate the anti-proliferative and apoptotic mechanisms of Evodiamine (Evo) in human gastric cancer cells (SGC-7901).
- To establish a cell synchronization model for detailed mechanistic studies of Evo.
- To elucidate the role of mitotic arrest and mitotic slippage in Evo-induced apoptosis.
Main Methods:
- Utilized a cell synchronization model in SGC-7901 human gastric cancer cells.
- Transfected cells with full-length or non-degradable (ND) cyclinB1 to assess Evo's effects.
- Investigated the impact of transient vs. sustained Evo treatment and CDK1 inhibition on apoptosis and mitotic events.
Main Results:
- Evodiamine (Evo) significantly inhibited SGC-7901 cell proliferation and exhibited cytotoxicity.
- Transient Evo treatment induced reversible mitotic arrest; sustained arrest (>16-20 hours) was necessary for apoptosis induction.
- Promoting mitotic slippage enhanced apoptosis, while delaying it via ND cyclinB1 overexpression reduced Evo's apoptotic effects.
Conclusions:
- Evodiamine (Evo)-induced apoptosis in gastric cancer cells is intrinsically linked to mitotic arrest and subsequent mitotic slippage.
- The findings suggest that Evo's anti-cancer properties may stem from its ability to disrupt mitotic progression and induce cell death.
- This study provides mechanistic insights into Evodiamine's potential as a therapeutic agent for cancer treatment and prevention.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
The Extrinsic Apoptotic Pathway
Drugs that Stabilize Microtubules
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
